Early Visionary
Manage Your Risk
If early investments in studies aren’t properly aligned and leveraged to address the diverse and significant demands of gatekeepers deciding the fate of your technology in the marketplace, you could run out of runway.
Strategic partnerships with KOLs and healthcare leaders are important, but they often have their own agendas that don’t align with yours.
Market opportunities that present themselves through these partnerships may not bear fruit or yield high ROI if they aren’t evaluated against a strategic market access plan and evidence development roadmap.
Management of these relationships and projects can quickly overcome your internal team and resources and create unnecessary tension within key relationships.
Optimize Your Opportunity
You have many opportunities to optimize your commercialization pathway and accelerate adoption and payment of your technology. Our custom solutions, listed below, are a great place to start ideating and we hope you’ll find it informative. That said, we’re really old school and what we’re most passionate about is helping you, the innovators and leaders who can take healthcare forward. So we’d love to hear your story.
SMART EvGen
Insights
How We Help Companies of All Sizes
You Don't Have to Do It Alone Bringing medical devices, biotechnology, and precision medicine to market [...]
Is Your LDT Headed Down a Dangerous Path?
Is Your LDT Headed Down a Dangerous Path? Does your go-to-market (GTM) plan include using existing test [...]
>75% of Medtech Startups Fail & This is Why
What Leads to Company Underperformance & Failure? As a medtech company operating in such a nuanced [...]
Know Where You Stand in the Product Lifecycle
Call Us, We’re Here For You